← Leaderboards
Bryan Lau
Johns Hopkins University
$14,932,508
Attributed
$20,630,553
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,630,553 · 10
By mechanism
R01$7,920,922 · 2
U01$6,924,039 · 2
P30$3,200,419 · 2
P01$1,068,729 · 1
K01$661,683 · 1
U19$500,697 · 1
Top collaborators
- Corinne E. Joshu10 shared
- Heidi M. Crane5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Chloe L Thio$13,807,555
- Linda J Van Eldik$37,023,709
- Corinne E. Joshu$4,440,829
- Gregory D Kirk$60,349,977
- Justin Richard Bailey$16,021,335
Others in their field
Top investigators on “Acquired Immunodeficiency Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$300,790,583
- George R Seage · Abt Associates, Inc.$244,444,207
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$180,045,219
- Barbara Driver · Westat, Inc.$168,632,670
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$150,146,659
Research focus
Acquired Immunodeficiency SyndromeEpidemiologyCohortCaringResourcesResearch PersonnelInnovationAreaResearch DesignBaseEpidemicCohort StudiesMethodologyBiostatistical MethodsCollaborationsContinuity Of Patient CareComorbidityLeadershipPersonsEpidemiologic MethodsBiometryProgramsHigh RiskCommunities
Grant awards (41)
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies$1,504,401
R01 · FY2025 · AI · contact PI
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV$700,257
R01 · FY2025 · CA
Statistical and Data Management Core$500,697
U19 · FY2025 · AI · contact PI
Biostatistics & Epidemiology Methodology Core$322,124
P30 · FY2025 · AI · contact PI
Alcohol Research Consortium in HIV: Biostatistics and Method Core$210,788
P01 · FY2025 · AA · contact PI
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies$776,684
R01 · FY2024 · AI · contact PI
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV$672,541
R01 · FY2024 · CA
Biostatistics & Epidemiology Methodology Core$362,754
P30 · FY2024 · AI · contact PI
Alcohol Research Consortium in HIV: Biostatistics and Method Core$209,851
P01 · FY2024 · AA · contact PI
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies$743,601
R01 · FY2023 · AI · contact PI
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV$673,296
R01 · FY2023 · CA
Biostatistics & Epidemiology Methodology Core$475,570
P30 · FY2023 · AI · contact PI
Alcohol Research Consortium in HIV: Biostatistics and Method Core$209,279
P01 · FY2023 · AA · contact PI
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies$818,748
R01 · FY2022 · AI · contact PI
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV$674,794
R01 · FY2022 · CA
Biostatistics & Epidemiology Methodology Core$562,838
P30 · FY2022 · AI · contact PI
Alcohol Research Consortium in HIV: Biostatistics and Method Core$211,913
P01 · FY2022 · AA · contact PI
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV$677,064
R01 · FY2021 · CA
Biostatistics and Epidemiology Methodology Core$351,102
P30 · FY2021 · AI · contact PI
Alcohol Research Consortium in HIV: Biostatistics and Method Core$226,898
P01 · FY2021 · AA · contact PI
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV$679,536
R01 · FY2020 · CA
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$669,602
U01 · FY2020 · AA
Biostatistics and Epidemiology Methodology Core$308,044
P30 · FY2020 · AI · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$680,962
U01 · FY2019 · AA
Biostatistics and Epidemiology Methodology Core$278,293
P30 · FY2019 · AI · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$686,094
U01 · FY2018 · AA
Biostatistics and Epidemiology Methodology Core$269,550
P30 · FY2018 · AI · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$697,668
U01 · FY2017 · AA
Lung and HIV Analytical Data Coordinating Center (LHAD-CC)$681,409
U01 · FY2017 · HL · contact PI
Biostatistics and Epidemiology Methodology Core$270,144
P30 · FY2017 · AI · contact PI
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)$740,843
U01 · FY2016 · AA
Lung and HIV Analytical Data Coordinating Center (LHAD-CC)$688,897
U01 · FY2016 · HL · contact PI
Lung and HIV Analytical Data Coordinating Center (LHAD-CC)$700,588
U01 · FY2015 · HL · contact PI
Lung and HIV Analytical Data Coordinating Center (LHAD-CC)$694,551
U01 · FY2014 · HL · contact PI
Lung and HIV Analytical Data Coordinating Center (LHAD-CC)$683,425
U01 · FY2013 · HL · contact PI
Global Immunological Response to Effective Antiretroviral Therapy (GiREAT:CD4)$354,064
R56 · FY2013 · AI · contact PI
Biomarkers, Therapy, and Mortality in the Evolving HIV Epidemic$134,192
K01 · FY2011 · AI · contact PI
Biomarkers, Therapy, and Mortality in the Evolving HIV Epidemic$131,706
K01 · FY2010 · AI · contact PI
Biomarkers, Therapy, and Mortality in the Evolving HIV Epidemic$130,458
K01 · FY2009 · AI · contact PI
Biomarkers, Therapy, and Mortality in the Evolving HIV Epidemic$130,327
K01 · FY2008 · AI · contact PI
Biomarkers, Therapy, and Mortality in the Evolving HIV Epidemic$135,000
K01 · FY2007 · AI · contact PI